Lineage Cell Therapeutics (LCTX) Short-term Investments (2017 - 2026)
Lineage Cell Therapeutics (LCTX) reported Short-term Investments of $13.47 million for Q2 2026, compared with $17,000 a year earlier and down 22.7% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Short-term Investments (2017 - 2026) Analysis & Trends
At the end of FY2025, Lineage Cell Therapeutics posted Short-term Investments of $14.99 million, up 643.6% from FY2024.
- Short-term Investments has a five-year compound annual growth rate of 10.8% (FY2020 to FY2025).
- By year, Short-term Investments came in at $2.02 million in FY2024, $50,000 in FY2023 (-99.9%), $46.52 million in FY2022 and $2.62 million in FY2021 (-70.9%).
- Five-year quarterly Short-term Investments spans a low of $17,000 in Q2 2025 and a high of $46.52 million in Q4 2022.
- Year over year, Short-term Investments gained in 1 of the last five quarters, with growth averaging 67.3%.
- The high point for year-over-year Short-term Investments in five years was Q2 2023 (growth of 926.3%); the low point was Q4 2023 (a decline of 99.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $17.44 million (Q1 2026), $14.99 million (Q4 2025) and $23,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.40 Bn | 1,112.99 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 634.88 Bn | 554.74 Bn | 17.30 Bn |
| 3 | AbbVie | 500.40 Bn | 473.51 Bn | 12.70 Bn |
| 4 | Merck | 356.05 Bn | 310.43 Bn | 12.21 Bn |
| 5 | Novartis Ag | 301.50 Bn | 265.49 Bn | 11.24 Bn |
| 6 | Astrazeneca | 264.72 Bn | 238.40 Bn | 12.86 Bn |
| 7 | Amgen | 238.14 Bn | 193.54 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.19 Bn | 169.39 Bn | 6.22 Bn |
| 9 | Pfizer | 171.40 Bn | 118.04 Bn | 10.94 Bn |
| 10 | Lineage Cell Therapeutics | 241.96 Mn | 41.49 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.47 Mn |
| Mar 31, 2026 | 17.44 Mn |
| Dec 31, 2025 | 14.99 Mn |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | 2.02 Mn |
| Sep 30, 2024 | 4.96 Mn |
| Jun 30, 2024 | 8.87 Mn |
| Mar 31, 2024 | 45,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 9.90 Mn |
| Jun 30, 2023 | 12.04 Mn |
| Mar 31, 2023 | 31.36 Mn |
| Dec 31, 2022 | 46.52 Mn |
| Sep 30, 2022 | 41.60 Mn |
| Jun 30, 2022 | 1.17 Mn |
| Mar 31, 2022 | 1.88 Mn |
| Dec 31, 2021 | 2.62 Mn |
| Sep 30, 2021 | 4.30 Mn |
API Access
Lineage Cell Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();